Metrika gets US nod for HbA1c test:
This article was originally published in Clinica
Executive Summary
Diagnostic firm Metrika has been given the green light to market in the US its point-of-care A1cNow INView multi-test system for monitoring levels of HbA1c, the current gold standard for diabetes control. Used in a doctor's office or at home, the pager-sized device provides laboratory-quality results in five minutes from a 10 microlitre finger prick sample. Doctors can then determine a patient's average blood sugar level over the previous 2-3 months, the Sunnyvale, California firm claims. Studies show that a 1% reduction in HbA1C can lower the risk of blindness, amputation, kidney and nerve disease by 40%. Metrika will introduce the system later this year.